Login to Your Account

Indevus Gains Pliva As Sanctura Partner Via Potential $215M Deal

By Karen Pihl-Carey

Thursday, April 8, 2004
As Indevus Pharmaceuticals Inc.'s overactive bladder product nears the market, the company laid out a U.S. commercialization plan with Zagreb, Croatia-based Pliva d.d. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription